Research community previously filed under “Oncology”

Transition Metal Complexes for Anticancer Therapy and Cisplatin Resistance

Mostly in the field Transition Metal Chemistry, Anticancer Therapy, and Catalysis (83% of its papers), one of 4 communities there

Papers 62,494
Elements 6
Keywords & sectors 73
Leading venue Inorganica Chimica Acta

Transition Metal Complexes for Anticancer Therapy and Cisplatin Resistance

This community designs and evaluates metal-based compounds—primarily platinum, ruthenium, and copper complexes—to treat cancer and to address the specific problem of resistance to cisplatin, a standard chemotherapy agent.

The work centers on the synthesis of coordination compounds, frequently using Schiff base ligands, followed by structural characterization and biological testing. Researchers investigate how these complexes interact with DNA and evaluate their anticancer activity against lung, breast, ovarian, and gastric cancers. A significant portion of the literature focuses on overcoming cisplatin resistance and mitigating cisplatin-induced kidney injury. Computational methods, such as molecular docking and density functional theory, are routinely used to model these interactions and predict biological activity before experimental validation.

The largest share of the community's output is found in platinum research, accounting for 14.6% of all platinum research, and 23,503 papers here. Ruthenium research represents 7.4% of that element's total output, with 5,776 papers in this group.

The community comprises 62,494 papers, published most frequently in Inorganica Chimica Acta, Journal of Inorganic Biochemistry, and Inorganic Chemistry.

Recent work continues to focus on the design of new ruthenium and iridium complexes for photoactivated therapies and the detailed study of copper complex mechanisms as anticancer agents.

Recurring themes in the literature

Phrases that recur across this community's paper titles -- a quick map of its sub-topics, drawn straight from the titles themselves.

  • cancer cells 1060
  • schiff base 740
  • lung cancer 728
  • cisplatin resistance 673
  • molecular docking 598
  • breast cancer 574
  • metal complexes 533
  • kidney injury 492
  • crystal structure 460
  • acute kidney 426
  • iii complexes 412
  • anticancer activity 380
  • copper complexes 366
  • cell lung 341
  • ovarian cancer 338
  • cancer cell 336
  • synthesis crystal 318
  • iridium iii 301
  • synthesis biological 298
  • dna binding 275
  • ruthenium complexes 271
  • biological evaluation 270
  • against cisplatin-induced 263
  • platinum complexes 260

Papers behind this description

Most cited
2026 · 265 citations
Scientific Reports · 2023 · 1187 citations
Theranostics · 2022 · 1032 citations
Molecular Biomedicine · 2025 · 155 citations
Drug Resistance Updates · 2024 · 236 citations
Newest
2026 · 265 citations
Scientific Reports · 2025 · 73 citations
Molecular Biomedicine · 2025 · 38 citations
Discover Chemistry. · 2026 · 19 citations
International Journal of Molecular Sciences · 2026 · 18 citations

A sample from the 16 papers behind this description. Create a free account to see them all.